Medication info
Empagliflozin 25 mg (Empagliflozin)

Empagliflozin 25 mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Light yellow oval film-coated tablet
Packaging
PTP - 30 tablets/PTP [30 tablets/PTP x 3], PTP - 10 tablets/PTP [10 tablets/PTP x 1]
Approval status
Active

MFDS item code 202105450 · Approved 2021.07.19 · Insurance code 642507870

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this drug is 10 mg once daily, either as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent estimated glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the estimated glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or receiving dialysis, as efficacy is not expected. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age or older. Initiation of this drug is not recommended in patients 85 years of age or older because clinical experience is limited.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control issues
  • cardiovascular diseases
View approved original text

This medication is used as an adjunct to dietary and exercise therapy to improve blood sugar control in adults with type 2 diabetes. It can be administered alone or in combination with other medications. It is particularly important to use caution in patients with type 2 diabetes who have cardiovascular disease and whose blood sugar is not sufficiently controlled; it is crucial to refer to expert guidelines regarding the occurrence of cardiovascular events. Overall, this medication is helpful in improving blood sugar control and is useful in diabetes management.

How to take

Adult dose

The recommended dose of this drug is 10 mg once daily, either as monotherapy or as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this drug is well tolerated and additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this drug is administered concomitantly with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This drug may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this drug should not be initiated in patients with an estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this drug well but have a persistent estimated glomerular filtration rate < 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. This drug should be discontinued if the estimated glomerular filtration rate decreases to < 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this drug in patients with end-stage renal disease (ESRD) or receiving dialysis, as efficacy is not expected. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this drug is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients 75 years of age or older. Initiation of this drug is not recommended in patients 85 years of age or older because clinical experience is limited.

Precautions

This medication should not be used in certain patients, such as those allergic to its ingredients, type 1 diabetes patients, patients with severely impaired kidney function, and those with genetic issues like lactose intolerance. For patients with slightly impaired kidney function, dosage adjustment is needed, and treatment should be discontinued in cases of severe kidney impairment. Additionally, this medication is not effective in patients with end-stage kidney disease or those on dialysis. In patients with mild to moderate heart failure, it should be used cautiously, and it is not recommended for patients with severe heart failure. The risk of hypoglycemia may increase when this medication is used in conjunction with insulin or insulin-releasing agents; therefore, dosage adjustments for those medications may be necessary. During the use of this medication, side effects such as hypoglycemia, urinary infections, genital infections, increased urination, fluid loss, etc., may occur, so caution is advised. Particularly careful monitoring is needed for elderly patients or those at risk of fluid loss. Furthermore, this medication can induce serious metabolic acidosis known as ketoacidosis, so if symptoms occur, immediate consultation with healthcare professionals is necessary. Ketoacidosis can manifest as symptoms such as vomiting, abdominal pain, and difficulty breathing. It is advisable to avoid using this medication during pregnancy, and breastfeeding women are recommended to stop breastfeeding. Safety and efficacy have not been established in children and adolescents, so they should not take this medication. No specific toxicity has been reported in cases of overdose, but appropriate management may be required based on clinical condition. Consider potential drug interactions when taking this medication, especially caution is needed when used concurrently with diuretics, insulin, sulfonylureas, etc. Lastly, when storing this medication, keep it out of reach of children and do not transfer it to other containers.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvar pruritus
  • balanitis
  • other genital infections
  • increased urination
  • urinary difficulty
  • interstitial nephritis
  • itching
  • rash
Show 12 more
  • urticaria
  • angioedema
  • decreased blood volume
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urinary tract infection
  • urosepsis
  • pyelonephritis
  • perineal necrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from exposure to air, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. By storing it this way, you can safely maintain the efficacy of the medication.

Appearance and packaging

Appearance

Light yellow oval film-coated tablet

Package unit

PTP - 30 tablets/PTP [30 tablets/PTP x 3], PTP - 10 tablets/PTP [10 tablets/PTP x 1]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.